You are here: Industry Insights > Glenmark Pharmaceuticals

News List

Russia claims Favipiravir shows promise against coronavirus in early trials expresspharma
May 14, 2020
Favipiravir is also undergoing trials in India by Glenmark Pharmaceuticals.
Glenmark launches triple therapy inhaler expresspharma
May 12, 2020
Reportedly, AIRZ-FF is India’s first Glycopyrronium + Formoterol + Fluticasone combination, exclusively studied in the Indian population.
Glenmark gets tentative USFDA approval for generic anti-diabetes tablets expresspharma
April 29, 2020
The approval is for the strength of 10 mg/5 mg tablets of Dapagliflozin and Saxagliptin.
Glenmark pledges 50 lakh meals for the needy amidst COVID-19 pandemic expresspharma
April 24, 2020
Additionally over 3,00,000 beneficiaries to be reached across Himachal Pradesh, Madhya Pradesh and Gujarat via tele-medicine by medical specialists.
Glenmark divests VWash, a female intimate hygiene wash, to Hindustan Unilever expresspharma
March 25, 2020
Glenmark will receive an upfront payment and royalty on sales for three years. No employees will be transferred as a part of this agreement.
Glenmark receives ANDA tentative approval for Dapagliflozin Tablets, 5 mg and 10 mg expresspharma
March 24, 2020
According to IQVIATM sales data for the 12 month period ending January 2020, the Farxiga Tablets, 5 mg and 10 mg market achieved annual sales of approximately $1.8 billion.
Glenmark Pharmaceuticals receives ANDA approval for Ranolazine expresspharma
July 09, 2019
Glenmark Pharmaceuticals has been granted final approval by the United States Food and Drug Administration (US FDA) for Ranolazine Extended-Release Tablets, 500 mg and 1,000 mg ...
Glenmark appoints Alessandro Riva as CEO of its New Innovation Company biospectrumasia
March 06, 2019
Glenmark Pharmaceuticals has announced that Alessandro Riva, MD, will join its new innovation company as Chief Executive Officer. Alessandro is currently Executive Vice President, Oncology Therapeutics and Cell Therapy for Gilead Sciences.
Glenmark Pharmaceuticals to establish new company in US pharmaceutical-technology
February 18, 2019
India-based Glenmark Pharmaceuticals is set to spin-off its innovation business into a new company in the US to increase focus on innovation and advance its pipeline towards commercialisation.....
Glenmark Pharmaceuticals Announces New Data Presentations on Ryaltris at the ACAAI Annual Scientific Meeting 2018 drugs
November 29, 2018
Glenmark Pharmaceuticals, a global pharmaceutical company, today announced that the company is presenting new data for for its leading respiratory pipeline candidate ....

Previous page 1 2 Next page